6.
Zheng D, Decker K, Zhou T, Chen J, Qi Z, Jacobs K
. Role of WNT7B-induced noncanonical pathway in advanced prostate cancer. Mol Cancer Res. 2013; 11(5):482-93.
PMC: 4141540.
DOI: 10.1158/1541-7786.MCR-12-0520.
View
7.
Dymova M, Vasileva N, Kuligina E, Savinovskaya Y, Zinchenko N, Ageenko A
. MicroRNA and mRNA Expression Changes in Glioblastoma Cells Cultivated under Conditions of Neurosphere Formation. Curr Issues Mol Biol. 2022; 44(11):5294-5311.
PMC: 9688839.
DOI: 10.3390/cimb44110360.
View
8.
Reinhold W, Sunshine M, Liu H, Varma S, Kohn K, Morris J
. CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. Cancer Res. 2012; 72(14):3499-511.
PMC: 3399763.
DOI: 10.1158/0008-5472.CAN-12-1370.
View
9.
Gao Q, Yang L, Shen A, Li Y, Li Y, Hu S
. A WNT7B-mA-TCF7L2 positive feedback loop promotes gastric cancer progression and metastasis. Signal Transduct Target Ther. 2021; 6(1):43.
PMC: 7851143.
DOI: 10.1038/s41392-020-00397-z.
View
10.
Liu L, Lv Z, Xue X, Xing Z, Zhu F
. Canonical WNT Signaling Activated by WNT7B Contributes to L-HBs-Mediated Sorafenib Resistance in Hepatocellular Carcinoma by Inhibiting Mitophagy. Cancers (Basel). 2022; 14(23).
PMC: 9741164.
DOI: 10.3390/cancers14235781.
View
11.
Moparthi L, Pizzolato G, Koch S
. Wnt activator FOXB2 drives the neuroendocrine differentiation of prostate cancer. Proc Natl Acad Sci U S A. 2019; 116(44):22189-22195.
PMC: 6825314.
DOI: 10.1073/pnas.1906484116.
View
12.
Kent W, Zweig A, Barber G, Hinrichs A, Karolchik D
. BigWig and BigBed: enabling browsing of large distributed datasets. Bioinformatics. 2010; 26(17):2204-7.
PMC: 2922891.
DOI: 10.1093/bioinformatics/btq351.
View
13.
Li T, Fan J, Wang B, Traugh N, Chen Q, Liu J
. TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017; 77(21):e108-e110.
PMC: 6042652.
DOI: 10.1158/0008-5472.CAN-17-0307.
View
14.
MacDonald B, Tamai K, He X
. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009; 17(1):9-26.
PMC: 2861485.
DOI: 10.1016/j.devcel.2009.06.016.
View
15.
Kirikoshi H, Sekihara H, Katoh M
. Molecular cloning and characterization of human WNT7B. Int J Oncol. 2001; 19(4):779-83.
DOI: 10.3892/ijo.19.4.779.
View
16.
Bonneville R, Krook M, Kautto E, Miya J, Wing M, Chen H
. Landscape of Microsatellite Instability Across 39 Cancer Types. JCO Precis Oncol. 2018; 2017.
PMC: 5972025.
DOI: 10.1200/PO.17.00073.
View
17.
Chiu D, Yuen V, Cheu J, Wei L, Ting V, Fehlings M
. Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice. Gastroenterology. 2020; 159(2):609-623.
DOI: 10.1053/j.gastro.2020.03.074.
View
18.
Sun W, Kang T, Wang Y, Sun J, Li C, Liu H
. Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410. Biosci Rep. 2018; 39(1).
PMC: 6328889.
DOI: 10.1042/BSR20180395.
View
19.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A
. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249.
DOI: 10.3322/caac.21660.
View
20.
Jaillon S, Ponzetta A, Di Mitri D, Santoni A, Bonecchi R, Mantovani A
. Neutrophil diversity and plasticity in tumour progression and therapy. Nat Rev Cancer. 2020; 20(9):485-503.
DOI: 10.1038/s41568-020-0281-y.
View